Similar articles

• [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].

  Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL. Qiu YG, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):710-4. Zhonghua Liu Xing Bing Xue Za Zhi. 2004. PMID: 15555399 Chinese.
• [The effect of the new angiotensin-converting enzyme inhibitor moexipril on the circadian rhythms of arterial pressure in hypertension patients].

  Ol'binskaia LI, Andrushchishina TB. Ol'binskaia LI, et al. Ter Arkh. 1997;69(3):58-61. Ter Arkh. 1997. PMID: 9229835 Clinical Trial. Russian.
• Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.

  Brugts JJ, Ferrari R, Simoons ML. Brugts JJ, et al. Expert Rev Cardiovasc Ther. 2009 Apr;7(4):345-60. doi: 10.1586/erc.09.2. Expert Rev Cardiovasc Ther. 2009. PMID: 19379059 Review.
• Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.

  White WB, Lacourciere Y, Gana T, Pascual MG, Smith DH, Albert KS. White WB, et al. Am Heart J. 2004 Oct;148(4):628-34. doi: 10.1016/j.ahj.2004.07.008. Am Heart J. 2004. PMID: 15459593 Clinical Trial.
• [Circadian changes in blood pressure and therapeutic consequences].

  Schrader J, Scheler F. Schrader J, et al. Internist (Berl). 1990 Oct;31(10):662-8. Internist (Berl). 1990. PMID: 2283211 Review. German. No abstract available.